IIGB/CEPCEB Chemist Michael Pirrung announced the development of a compound with the potential to fight renal cancer in a lecture he gave on Feb. 19 at the 5th International Conference on Drug Discovery and Therapy, held in Dubai, UAE. Named TIR-199, the compound targets the “proteasome,” a cellular complex in kidney cancer cells, similar to...